Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2018, Article ID 4783093, 8 pages
https://doi.org/10.1155/2018/4783093
Research Article

The Effect of Thyroid Dysfunction on the Cardiovascular Risk of Type 2 Diabetes Mellitus Patients in Ghana

1Komfo Anokye Teaching Hospital, Kumasi, Ghana
2Kwame Nkrumah University of Science and Technology, Kumasi, Ghana

Correspondence should be addressed to Osei Sarfo-Kantanka; moc.liamg@12aknatnakofraso

Received 5 July 2017; Revised 14 October 2017; Accepted 30 October 2017; Published 1 February 2018

Academic Editor: Eusebio Chiefari

Copyright © 2018 Osei Sarfo-Kantanka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “International Diabetes Federation IDF diabetes atlas,” March 2017, http://www.diabetesatlas.org/resources/2015-atlas.htlm.
  2. L. Chen, D. J. Magliano, and P. Z. Zimmet, “The worldwide epidemiology of type 2 diabetes mellitus–present and future perspectives,” Nature Reviews Endocrinology, vol. 8, no. 4, pp. 228–236, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. WHO, “Global status report on non-communicable diseases 2010,” March 2017, http://www.who.int/nmh/publications/ncd_report2010/en/.
  4. A. G. Amoah, S. K. Owusu, and S. Adjei, “Diabetes in Ghana: a community-based prevalence study in Greater Accra,” Diabetes Research and Clinical Practice, vol. 56, no. 3, pp. 197–205, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. S. M. Haffner, S. Lehto, T. Ronnemaa, K. Pyörälä, and M. Laakso, “Mortality from coronary heart disease in subjects with type 2 diabetes and non-diabetic subjects with and without prior myocardial infarction,” The New England Journal of Medicine, vol. 339, no. 4, pp. 229–234, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Juutilainen, S. Lehto, T. Rönnemaa, K. Pyörälä, and M. Laakso, “Type 2 diabetes as a “coronary heart disease equivalent”: an 18-year prospective population-based study in Finnish subjects,” Diabetes Care, vol. 28, no. 12, pp. 2901–2907, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Stamler, O. Vaccaro, J. D. Neaton, D. Wentworth, and The Multiple Risk Factor Intervention Trial Research Group, “Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial,” Diabetes Care, vol. 16, no. 2, pp. 434–444, 1993. View at Publisher · View at Google Scholar · View at Scopus
  8. Diabetes drafting group, “Prevalence of small vessel disease and large vessel disease in diabetic patients from 14 centers. The World Health Organization Multinational Study of Vascular Disease in diabetics,” Diabetologia, vol. 28, Supplement 1, pp. 615–640, 1985. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Sathish and V. Mohan, “Diabetes and thyroid diseases- a review,” International Journal of Diabetes in Developing Countries, vol. 23, no. 4, pp. 120–123, 2003. View at Google Scholar
  10. S. Danzi and I. Klein, “Thyroid hormone and blood pressure regulation,” Current Hypertension Reports, vol. 5, no. 6, pp. 513–520, 2003. View at Publisher · View at Google Scholar
  11. E. A. Palmieri, S. Fazio, G. Lombardi, and B. Biondi, “Subclinical hypothyroidism and cardiovascular risk: a reason to treat?” Treatments in Endocrinology, vol. 3, no. 4, pp. 233–244, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. S. A. Chubb, W. A. Davis, and Z. Inman, “Prevalence and progression of subclinical hypothyroidism in women with type 2 diabetes: the Fremantle diabetes study,” Clinical Endocrinology, vol. 62, no. 4, pp. 480–486, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Haentjens, A. Van Meerhaeghe, K. Poppe, and B. Velkeniers, “Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies,” European Journal of Endocrinology, vol. 159, no. 3, pp. 329–341, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Sathyapalan, A. M. Manuchehri, A. S. Rigby, and S. L. Atkin, “Subclinical hypothyroidism is associated with reduced all-cause mortality in patients with type 2 diabetes,” Diabetes Care, vol. 33, no. 3, article e37, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Ochs, R. Auer, D. C. Bauer et al., “Meta-analysis: subclinical thyroid dysfunction and the risk of coronary heart disease and mortality,” Annals of Internal Medicine, vol. 148, no. 11, pp. 832–845, 2008. View at Publisher · View at Google Scholar
  16. S. Razvi, A. Shakoor, M. Vanderpump, J. U. Weaver, and S. H. S. Pearce, “The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis,” The Journal of Clinical Endocrinology & Metabolism, vol. 93, no. 8, pp. 2998–3007, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. F. J. del Canizo-Gomez and M. N. Moreira-Andres, “Stick control of modifiable risk factors for type 2 diabetes,” The New England Journal of Medicine, vol. 348, no. 5, pp. 383–393, 2003. View at Google Scholar
  18. R. B. D’Agostino Sr., R. S. Vasan, M. J. Pencina et al., “General cardiovascular risk profile for use in primary care: the Framingham heart study,” Circulation, vol. 117, no. 6, pp. 743–753, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. The University of Oxford, Diabetes trial unit, “The Oxford Centre for Diabetes, Endocrinology and Metabolism, UKPDS risk engine,” February 2017, http://www.dtu.ox.ac.uk/riskengine/download.php.
  20. WHO/NCD/NCS/99.2, WHO Consultation. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation Part 1: Diagnosis and Classification of Diabetes Mellitus, World Health Organization, Geneva, 1999, Publication no. WHO/NCD/NCS/99.2.
  21. S. G. Wannamethee, A. G. Shaper, and I. J. Perry, “British regional heart study: smoking as a modifiable risk factor for type 2 diabetes in middle-aged men,” Diabetes Care, vol. 204, no. 9, pp. 1590–1595, 2001. View at Google Scholar
  22. A. G. Shaper, G. Wanathee, and M. Walker, “Alcohol and mortality in British: explaining the U shaped curve,” The Lancet, vol. 332, no. 8623, pp. 1267–1273, 1988. View at Publisher · View at Google Scholar · View at Scopus
  23. World Health Organisation, Obesity: Prevention and Managing the Global Epidemic. Report of a WHO Consultation, WHO Technical Report Series 894, Geneva, 2000, http://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/.
  24. J. Chalmers, S. McMahon, G. Mancia et al., “1999 World Health Organisation-International Society of Hypertension Guidelines for treatment of hypertension,” Clinical and Experimental Hypertension, vol. 21, no. 5-6, pp. 1009–1060, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. O. Sarfo-Kantanka, F. S. Sarfo, E. O. Ansah et al., “Frequency and determinants of thyroid autoimmunity in Ghanaian type 2 diabetes patients: a case-control study,” BMC Endocrine Disorders, vol. 17, no. 1, p. 2, 2017. View at Publisher · View at Google Scholar · View at Scopus
  26. P. W. Wilson, R. B. D’Agostino, D. Levy, A. M. Belanger, H. Silbershatz, and W. B. Kannel, “Prediction of coronary heart disease using risk factor categories,” Circulation, vol. 97, no. 18, pp. 1837–1847, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. S. N. Darko, D. D. Yar, E. Owusu-Dabo et al., “Variations in levels of IL-6 and TNF-α in type 2 diabetes mellitus between rural and urban Ashanti Region of Ghana,” BMC Endocrine Disorders, vol. 15, no. 1, p. 50, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Hu, P. Jousilahti, Q. Qiao, S. Katoh, and J. Tuomilehto, “Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without a history of myocardial infarction,” Diabetologia, vol. 48, no. 5, pp. 856–861, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. W. L. Lee, A. M. Cheung, D. Cape, and B. Zinman, “Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies,” Diabetes Care, vol. 23, no. 7, pp. 962–968, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Huxley, F. Barzi, and M. Woodward, “Excess risk of coronary heart diseases associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies,” BMJ, vol. 332, no. 7533, pp. 73–78, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Martin-Timon, C. Sevillano- Collantes, A. Sejura-Galindo, and F. J. Del Cañizo-Gómez, “Type 2 diabetes and cardiovascular disease: have all the risk factors the same strength?” World Journal of Diabetes, vol. 5, no. 4, pp. 444–470, 2014. View at Publisher · View at Google Scholar
  32. H. O. Steinberg, G. Paradisi, J. Cronin et al., “Type II diabetes abrogates sex differences in endothelial function in premenopausal women,” Circulation, vol. 101, no. 17, pp. 2040–2046, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. A. M. Kanaya, D. Grady, and E. Barrett-Connor, “Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis,” Archives of Internal Medicine, vol. 162, no. 15, pp. 1737–1745, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. A. A. Rivellese, G. Riccardi, and O. Vaccaro, “Cardiovascular risk in women with diabetes,” Nutrition, Metabolism & Cardiovascular Diseases, vol. 20, no. 6, pp. 474–480, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. C. S. Fox, “Cardiovascular disease risk factors, type 2 diabetes mellitus and the Framingham free heart study,” Trends in Cardiovascular Medicine, vol. 20, no. 3, pp. 90–95, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. A. R. Cappola, L. P. Fried, A. M. Arnold et al., “Thyroid status, cardiovascular risk, and mortality in older adults,” JAMA, vol. 295, no. 9, pp. 1033–1041, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Adeniye, A. R. Folson, F. Z. Brancati, M. Desvorieux, J. S. Pankow, and H. Taylor, “Incidence and risk factors of African American with diabetes: atherosclerosis risk in communities (ARIC) study,” Journal of the National Medical Association, vol. 94, no. 12, pp. 1025–1035, 2002. View at Google Scholar
  38. G. Iervasi, S. Molinaro, P. Landi et al., “Association between increased mortality and mild thyroid dysfunction in cardiac patients,” Archives of Internal Medicine, vol. 167, no. 14, pp. 1526–1532, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. M. B. Gomes, D. Giannella-Neto, M. Faria et al., “Estimating cardiovascular risk in patients with type 2 diabetes: a national multicenter study in Brazil,” Diabetology & Metabolic Syndrome, vol. 1, no. 1, p. 22, 2009. View at Publisher · View at Google Scholar
  40. M. Laakso, “Cardiovascular disease in type 2 diabetes from population to man to mechanisms,” Diabetes Care, vol. 33, no. 2, pp. 442–449, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Y. Gebreab and A. V. Diez Roux, “Exploring racial disparities in CHD mortality between blacks and whites across the United States: a geographically weighted regression approach,” Health & Place, vol. 18, no. 5, pp. 1006–1014, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. I. L. G. Todorova, K. L. Tucker, M. P. Jimenez, A. K. Lincoln, S. Arevalo, and L. M. Falcón, “Determinants of self-rated health and the role of acculturation: implications for health inequalities,” Ethnicity & Health, vol. 18, no. 6, pp. 563–585, 2013. View at Publisher · View at Google Scholar · View at Scopus